Actinogen Medical Ltd

ACW

Company Profile

  • Business description

    Actinogen Medical Ltd is a biotechnology company. The company develops a novel therapy for neurological and neuropsychiatric diseases associated with dysregulated cortisol in the brain. It is focused on the clinical development of Xanamem, an oral medication for neurological diseases amenable to its mechanism of lowering cortisol in brain cells. Geographically, the company's income is derived in Australia.

  • Contact

    109 Pitt Street
    Level 9, Suite 901
    SydneyNSW2000
    AUS

    T: +61 289647401

    https://www.actinogen.com.au

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2026

    Employees

Stocks News & Analysis

stocks

Will China strong arm BHP into lower iron ore prices?

Allegations that the Chinese government told steel mills to stop buying from BHP shake markets.
stocks

Chart of the Week: Where Morningstar sees attractive dividend yields in 26/27

Charts from the Australian Dividend Outlook show the sectors where they are abundant.
stocks

2 picks in an undervalued ASX sector

Investors may be too pessimistic about this industry.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,276.6019.90-0.21%
CAC 408,085.4425.310.31%
DAX 4024,702.41105.280.43%
Dow JONES (US)46,601.781.20-0.00%
FTSE 1009,523.5425.33-0.27%
HKSE26,752.5976.87-0.29%
NASDAQ23,043.38255.021.12%
Nikkei 22548,580.44845.451.77%
NZX 50 Index13,570.862.380.02%
S&P 5006,753.720.000.00%
S&P/ASX 2008,969.8025.20-0.28%
SSE Composite Index3,933.9751.201.32%

Market Movers